VuCOMP, leading developer of advanced computer vision systems for the detection of breast cancer, announced that it will be showcasing its portfolio of cutting-edge imaging products at the 20th Annual Mammography in Santa Fe: Music, Mammograms, and Mountains, August 3-7, 2015.
The meeting attracts breast imaging professionals from around the country.
VuCOMP will be highlighting the latest enhancements to the M-Vu System, as well as a works-in-progress CAD solution for 3D breast tomosynthesis.
"VuCOMP is pleased to share the latest features of our product line, as well as share advancements on our works-in-progress CAD for breast tomosynthesis solution," said Jim Pike, President and CTO of VuCOMP.
M-Vu CAD for mammography is the first mammography CAD proven effective in an FDA-approved reader study. The latest advancements provide radiologists with a substantial reduction in false positive marks and a lower false positive rate while improving sensitivity.
In addition, 3D tomosynthesis has continued to gain widespread acceptance, and with that comes the need for a CAD solution specifically designed to analyze the vast amount of information that tomosynthesis provides.
VuCOMP engineers have been working diligently on a cutting-edge solution that is designed to identify regions of interest that are consistent with breast cancer. Ultimately, providing the radiologist with another tool precisely designed for 3D tomosynthesis.
VuCOMP leads the way in setting a new standard for computer-aided detection. The company is dedicated exclusively to developing advanced cancer detecting technologies.
VuCOMP’s engineering team has worked together since 1986, pioneering some of the world’s most advanced computer vision systems.